An analysis of the rewarding and aversive associative properties of nicotine in the neonatal quinpirole model: Effects on glial cell line-derived neurotrophic factor (GDNF)

被引:10
作者
Brown, Russell W. [1 ]
Kirby, Seth L. [2 ]
Denton, Adam R. [2 ]
Dose, John M. [3 ]
Cummins, Elizabeth D. [2 ]
Gill, Wesley Drew [1 ]
Burgess, Katherine C. [1 ]
机构
[1] East Tennessee State Univ, James H Quillen Coll Med, Dept Biomed Sci, Johnson City, TN 37614 USA
[2] East Tennessee State Univ, Dept Psychol, Johnson City, TN 37614 USA
[3] St Norbert Coll, Dept Psychol, De Pere, WI 54115 USA
关键词
Dopamine D2 receptor; Schizophrenia; Adolescence; Nicotine; Antipsychotics; Conditioned place preference; CONDITIONED PLACE PREFERENCE; CUE-INDUCED REINSTATEMENT; VENTRAL TEGMENTAL AREA; NUCLEUS-ACCUMBENS; ANTIPSYCHOTIC-DRUGS; DOPAMINE ANTAGONISTS; PARKINSONS-DISEASE; LOCOMOTOR-ACTIVITY; SEEKING BEHAVIOR; RATS;
D O I
10.1016/j.schres.2017.03.024
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
This study analyzed the associative properties of nicotine in a conditioned place preference (CPP) paradigm in adolescent rats neonatally treated with quinpirole (NQ) or saline (NS). NQ produces dopamine D2 receptor super-sensitivity that persists throughout the animal's lifetime, and therefore has relevance towards schizophrenia. In two experiments, rats were ip administered quinpirole (1 mg/kg) or saline from postnatal day (P) 1-21. After an initial preference test at P42-43, animals were conditioned for eight consecutive days with saline or nicotine (0.6 mg/kg free base) in Experiment 1 or saline or nicotine (1.8 mg/kg free base) in Experiment 2. In addition, there were NQ and NS groups in each experiment given the antipsychotic haloperidol (0.05mg/kg) or clozapine (2.5 mg/kg) before nicotine conditioning. A drug free post-conditioning testwas administered at P52. At P53, the nucleus accumbens (NAc) was analyzed for glial cell-line derived neurotrophic factor (GDNF). Results revealed that NQ enhanced nicotine CPP, but blunted the aversive properties of nicotine. Haloperidol was more effective than clozapine at blocking nicotine CPP in Experiment 1, but neither antipsychotic affected nicotine conditioned place aversion in Experiment 2. NQ increased accumbal GDNF which was sensitized in NQ rats conditioned to nicotine in Experiment 1, but the aversive dose of nicotine reduced GDNF in NQ animals in Experiment 2. Both antipsychotics in combination with the aversive dose of nicotine decreased accumbal GDNF. In sum, increased D2 receptor sensitivity influenced the associative properties and GDNF response to nicotine which has implications towards pharmacological targets for smoking cessation in schizophrenia. (C) 2017 Elsevier B.V. All rights reserved.
引用
收藏
页码:107 / 114
页数:8
相关论文
共 50 条
  • [31] Controlled release of glial cell line-derived neurotrophic factor from poly(ε-caprolactone) microspheres
    Agbay, Andrew
    Mohtaram, Nima Khadem
    Willerth, Stephanie Michelle
    DRUG DELIVERY AND TRANSLATIONAL RESEARCH, 2014, 4 (02) : 159 - 170
  • [32] Association between smoking behaviour and genetic variants of glial cell line-derived neurotrophic factor
    Kotyuk, Eszter
    Nemeth, Nora
    Ronai, Zsolt
    Demetrovics, Zsolt
    Sasvari-Szekely, Maria
    Szekely, Anna
    JOURNAL OF GENETICS, 2016, 95 (04) : 811 - 818
  • [33] Glial cell line-derived neurotrophic factor in the substantia nigra from control and parkinsonian brains
    Mogi, M
    Togari, A
    Kondo, T
    Mizuno, Y
    Kogure, O
    Kuno, S
    Ichinose, H
    Nagatsu, T
    NEUROSCIENCE LETTERS, 2001, 300 (03) : 179 - 181
  • [34] Evaluation of an AAV2-Based Rapamycin-Regulated Glial Cell Line-Derived Neurotrophic Factor (GDNF) Expression Vector System
    Hadaczek, Piotr
    Beyer, Janine
    Kells, Adrian
    Narrow, Wade
    Bowers, William
    Federoff, Howard J.
    Forsayeth, John
    Bankiewicz, Krystof S.
    PLOS ONE, 2011, 6 (11):
  • [35] Glial cell line-derived neurotrophic factor (GDNF) gene delivery protects cortical neurons from dying following a traumatic brain injury
    Minnich, Jennie E.
    Mann, Sarah L.
    Stock, Megan
    Stolzenbach, Kathryn A.
    Mortell, Bridget M.
    Soderstrom, Katherine E.
    Bohn, Martha C.
    Kozlowski, Dorothy A.
    RESTORATIVE NEUROLOGY AND NEUROSCIENCE, 2010, 28 (03) : 293 - 309
  • [36] Unraveling the role of glial cell line-derived neurotrophic factor in the treatment of Parkinson's disease
    Kakoty, Violina
    Sarathlal, K. C.
    Kaur, Palwinder
    Wadhwa, Pankaj
    Vishwas, Sukriti
    Khan, Farhan R.
    Alhazmi, Abdulfattah Yahya M.
    Almasoudi, Hassan Hussain
    Gupta, Gaurav
    Chellappan, Dinesh Kumar
    Paudel, Keshav Raj
    Kumar, Dileep
    Dua, Kamal
    Singh, Sachin Kumar
    NEUROLOGICAL SCIENCES, 2024, 45 (04) : 1409 - 1418
  • [37] Cloning of glial cell line-derived neurotrophic factor gene and its expression in eukaryotic cells
    Jiang, Q
    Liu, J
    Ge, K
    Liu, WC
    Sun, LY
    Liu, XY
    Zheng, ZC
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 1999, 31 (02): : 150 - 154
  • [38] Grafting of nigral tissue hibernated with tirilazad mesylate and glial cell line-derived neurotrophic factor
    Petersén, Å
    Hansson, O
    Emgård, M
    Brundin, P
    CELL TRANSPLANTATION, 2000, 9 (05) : 577 - 584
  • [39] Controlled release of glial cell line-derived neurotrophic factor from poly(ε-caprolactone) microspheres
    Andrew Agbay
    Nima Khadem Mohtaram
    Stephanie Michelle Willerth
    Drug Delivery and Translational Research, 2014, 4 : 159 - 170
  • [40] Diverse glial cell line-derived neurotrophic factor (GDNF) support between mania and schizophrenia: A comparative study in four major psychiatric disorders
    Tunca, Z.
    Akdede, B. Kivircik
    Ozerdem, A.
    Alkin, T.
    Polat, S.
    Ceylan, D.
    Bayin, M.
    Kocuk, N. Cengizcetin
    Simsek, S.
    Resmi, H.
    Akan, P.
    EUROPEAN PSYCHIATRY, 2015, 30 (02) : 198 - 204